Multiple effector functions mediated by human immunodeficiency virus-specific CD4+ T-cell clones

Journal of Virology

Volumn 75, Issue 20, 2001, Pages 9771-9779

  Norris, P J ^a   Sumaroka, M ^a   Brander, C ^a   Moffett, H F ^a   Boswell, S L ^a   Nguyen, T ^a   Sykulev, Y ^a   Walker, B D ^a   Rosenberg, E S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CONCANAMYCIN A; EGTAZIC ACID; EPITOPE; FAS ANTIBODY; GAG PROTEIN; GAMMA INTERFERON; PERFORIN;

ARTICLE; CELL PROLIFERATION; CLONE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIBODIES; ANTIGENS, CD95; BREFELDIN A; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYCLOPHILINS; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; EGTAZIC ACID; EPITOPES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; MACROLIDES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0034802040     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.20.9771-9779.2001     Document Type: Article

References (56)

1. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection
2. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
3. Selective expansion of cytotoxic T lymphocytes with a CD4+ CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus
4. Control of viremia and prevention of clinical AIDS in Rhesus monkeys by cytokine-augmented DNA vaccination
5. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice
6. EBNA1-specific CD4(+) T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
7. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A
8. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription
9. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells
10. The influence of HLA class II allele DQBI*0301 on HCV-specific T helper responses
11. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones
12. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction
13. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C
14. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection
15. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines
16. Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo
17. Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques
18. Protective cellular retroviral immunity requires both CD4+ and CDS+ immune T cells
19. CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection
20. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens
21. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
22. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
23. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy
24. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin-and Fas-based tytic pathways in cell-mediated cytotoxicity
25. Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men
26. Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): Influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity
27. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes
28. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms
29. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment
30. A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: Cytotoxic activity and secretion of interleukin-2 and interleukin-6
31. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
32. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment
33. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
34. Association between MHC class II alleles and clearance of circulating hepatitis C virus
35. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines
36. A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses
37. Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine
38. The role of CD4(+) T cell help and CD40 ligand in the In vitro expansion of HIV-1-specific memory cytotoxic CD8(+) T cell responses
39. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires
40. The crystal structure of a T cell receptor in complex with peptide and MHC class II
41. Immune control of HIV-1 after early treatment of acute infection
42. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
43. The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8- T cells and is restricted to the DR region of the MHC complex
44. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones
45. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity
46. Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine
47. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes
48. Production and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein
49. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
50. Establishment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones
51. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells
52. Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones
53. Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes
54. Viral immune evasion due to persistence of activated T cells without effector function